retatrutide triple agonist phase 2 nejm 2023 obesity results GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Eli Lilly's Retatrutide Advances Toward

Do you think the committee will follow the agency scientists or could other pressures sway the decision

Monitor INR when warfarin is co-administered with GLP-1 analogues

To better understand the FDAs perspective on GLP-1 compounding, you can read: The FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss The FDAs Policies for Compounders As National GLP-1 Supply Begins To Stabilize The FDAs Guidance on Drug Products That Are Essentially Copies For consistent results and safety, the best GLP-1 for weight loss is an FDA-approved version from a reliable source

J., VanHeest, J., & Fernandez, M

Its a far more elegant approach than starting high and dealing with a cascade of unwanted variables